Home › Funds › CenterBook Partners LP › ABVX

CenterBook Partners LP position in ABVX

ABIVAX SA · Health Care

CenterBook Partners LP reported holding 142,496 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$14.1M, representing 0.65% of its reported portfolio and ranking #27 among its reported holdings. CenterBook Partners LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)142.50K sh
Reported value held$14.11M
Portfolio Weight0.65%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CenterBook Partners LP's ABVX position evolved

CenterBook Partners LP first disclosed a stake in ABVX in Q4 2025 at 7,176 shares (US$968K). The position peaked in Q3 2026 at 142,496 shares, worth US$14.1M. Across 4 filings, CenterBook Partners LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 142,496 shares valued at US$14.1M — an increase of 108,685 shares quarter over quarter.. Notable position changes include a 301% increase in Q2 2026 (shares fell 26% over the following quarter), a 321% increase in Q3 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 7.18K $967.72K New
Q1 2026 8.44K $939.35K Add
Q2 2026 33.81K $4.51M Add
Q3 2026 142.50K $14.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 71 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has CenterBook Partners LP held ABVX?

CenterBook Partners LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is CenterBook Partners LP's current position in ABVX?

As of Q3 2026, CenterBook Partners LP holds 142.50K shares of ABVX (ABIVAX SA), valued at $14.11M, representing 0.65% of its reported portfolio and ranking #27.

Has CenterBook Partners LP been buying or selling ABVX?

In the latest 13F filing (Q3 2026), CenterBook Partners LP increased its position in ABVX. The position peaked in Q3 2026 at 142.50K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.